SCHEMBL20951352

SCHEMBL20951352

CC(C)CC(NC(=O)C(CCCCNC(=O)O)NC(=O)C1CC1)C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 5/20 0.45
▸ SIRT5 Q9NXA8 1/20 0.43
▸ EED O75530 1/20 0.42
▸ NPY4R P50391 5/20 0.41
▸ NPY1R P25929 4/20 0.41
▸ NPY2R P49146 4/20 0.41
▸ NPY5R Q15761 4/20 0.41
▸ CAPN1 P07384 2/20 0.41
▸ CTSK P43235 2/20 0.41
▸ CAPN9 O14815 1/20 0.41
▸ CTSL P07711 1/20 0.41
▸ CTSB P07858 1/20 0.41
▸ CTSH P09668 1/20 0.41
▸ CTSS P25774 1/20 0.41
▸ CTSC P53634 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20951350 1.00 KISS1R (0.45) KISS1RSIRT5EEDNPY4RNPY1R
SCHEMBL20951656 0.97 KISS1R (0.48) KISS1REEDNPY4RNPY1RNPY2R
SCHEMBL20951659 0.97 KISS1R (0.48) KISS1REEDNPY4RNPY1RNPY2R
SCHEMBL20951952 0.96 KISS1R (0.46) KISS1RSIRT5EEDNPY4RNPY1R
SCHEMBL20951954 0.96 KISS1R (0.46) KISS1RSIRT5EEDNPY4RNPY1R
SCHEMBL20950991 0.92 KISS1R (0.48) KISS1REEDNPY4RNPY1RNPY2R
SCHEMBL20950992 0.92 KISS1R (0.48) KISS1REEDNPY4RNPY1RNPY2R
SCHEMBL20951500 0.87 SIRT5 (0.48) KISS1RSIRT5NPY4RNPY1RNPY2R
SCHEMBL20951499 0.87 SIRT5 (0.48) KISS1RSIRT5NPY4RNPY1RNPY2R
SCHEMBL20950987 0.86 KLKB1 (0.47) EEDCTSKCTSLCTSBCTSH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046729-B2 Dipeptide analogs as TGF-beta inhibitors SOUTHERN RESEARCH INSTITUTE (US) 2021-06-29 — — US disclosed
US-20190127420-A1 DIPEPTIDE ANALOGS AS TGF-BETA INHIBITORS UAB RESEARCH FOUNDATION 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127420-A1 DIPEPTIDE ANALOGS AS TGF-BETA INHIBITORS TGFB1, TGFB2, SMAD3 KISS1R 2444/4885SIRT5 2054/4885EED 2449/4885
US-11046729-B2 Dipeptide analogs as TGF-beta inhibitors TGFB1, TGFB2, SMAD3 KISS1R 2444/4885SIRT5 2054/4885EED 2449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback